JP2018526405A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018526405A5 JP2018526405A5 JP2018512525A JP2018512525A JP2018526405A5 JP 2018526405 A5 JP2018526405 A5 JP 2018526405A5 JP 2018512525 A JP2018512525 A JP 2018512525A JP 2018512525 A JP2018512525 A JP 2018512525A JP 2018526405 A5 JP2018526405 A5 JP 2018526405A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- group
- groups
- cycloalkyl
- substituted
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP15184449.5 | 2015-09-09 | ||
| EP15184449 | 2015-09-09 | ||
| EP16154638.7 | 2016-02-08 | ||
| EP16154638 | 2016-02-08 | ||
| PCT/EP2016/070839 WO2017042121A1 (en) | 2015-09-09 | 2016-09-05 | [{[2,3-dihydro-1h-inden-1-yl]amino}-2h,3h-furo[3,2-b]pyridin-3-yl]acetic acids, pharmaceutical compositions and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2018526405A JP2018526405A (ja) | 2018-09-13 |
| JP2018526405A5 true JP2018526405A5 (enExample) | 2019-09-05 |
Family
ID=56855466
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018512525A Pending JP2018526405A (ja) | 2015-09-09 | 2016-09-05 | ［｛［２，３−ジヒドロ−１Ｈ−インデン−１−イル］アミノ｝−２Ｈ，３Ｈ−フロ［３，２−ｂ］ピリジン−３−イル］酢酸、それらの医薬組成物および使用 |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US20180354962A1 (enExample) |
| EP (1) | EP3347358B1 (enExample) |
| JP (1) | JP2018526405A (enExample) |
| WO (1) | WO2017042121A1 (enExample) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3544958B1 (en) * | 2016-11-28 | 2021-03-24 | Boehringer Ingelheim International GmbH | Indanylaminopyridylcyclopropanecarboxylic acids, pharmaceutical compositions and uses thereof |
| JP6968181B2 (ja) * | 2017-01-26 | 2021-11-17 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | インダニルアミノピラジニルシクロプロパンカルボン酸、その医薬組成物及び使用 |
| US10550127B1 (en) * | 2017-02-08 | 2020-02-04 | Boehringer Ingelheim International Gmbh | Indanylaminoazadihydrobenzofuranylacetic acids, pharmaceutical compositions for the treatment of diabetes |
| JP7062792B2 (ja) | 2018-02-13 | 2022-05-06 | ギリアード サイエンシーズ， インコーポレイテッド | Ｐｄ－１／ｐｄ－ｌ１阻害剤 |
| US10568874B2 (en) | 2018-02-22 | 2020-02-25 | Chemocentryx, Inc. | Indane-amines as PD-L1 antagonists |
| CA3093851A1 (en) | 2018-03-29 | 2019-10-03 | Arbutus Biopharma Corporation | Substituted 1,1'-biphenyl compounds, analogues thereof, and methods using same |
| EP3781556B1 (en) | 2018-04-19 | 2025-06-18 | Gilead Sciences, Inc. | Pd-1/pd-l1 inhibitors |
| CN118221646A (zh) | 2018-07-13 | 2024-06-21 | 吉利德科学公司 | Pd-1/pd-l1抑制剂 |
| KR102635333B1 (ko) | 2018-10-24 | 2024-02-15 | 길리애드 사이언시즈, 인코포레이티드 | Pd-1/pd-l1 억제제 |
| JP2022552655A (ja) | 2019-10-07 | 2022-12-19 | キャリーオペ，インク． | Ｇｐｒ１１９アゴニスト |
| PH12022552277A1 (en) | 2020-02-28 | 2024-03-04 | Kallyope Inc | Gpr40 agonists |
| CA3178994A1 (en) | 2020-05-19 | 2021-11-25 | Iyassu Sebhat | Ampk activators |
| JP2023531726A (ja) | 2020-06-26 | 2023-07-25 | キャリーオペ，インク． | Ａｍｐｋアクチベーター |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1726580A4 (en) * | 2004-03-15 | 2008-02-13 | Takeda Pharmaceutical | AMINOPHNYLPROPANO ACID DERIVATIVE |
| WO2010143733A1 (en) * | 2009-06-09 | 2010-12-16 | Takeda Pharmaceutical Company Limited | Novel fused cyclic compound and use thereof |
| US8642585B2 (en) * | 2012-03-26 | 2014-02-04 | Boehringer Ingelheim International Gmbh | Indanyloxydihydrobenzofuranylacetic acids |
| WO2014019186A1 (en) * | 2012-08-02 | 2014-02-06 | Merck Sharp & Dohme Corp. | Antidiabetic tricyclic compounds |
| EP3036237A4 (en) * | 2013-08-23 | 2017-01-25 | Fujian Haixi Pharmaceuticals Co. Ltd | Carboxylic acid compounds in treatment of diabetes mellitus |
-
2016
- 2016-09-05 EP EP16760492.5A patent/EP3347358B1/en active Active
- 2016-09-05 WO PCT/EP2016/070839 patent/WO2017042121A1/en not_active Ceased
- 2016-09-05 JP JP2018512525A patent/JP2018526405A/ja active Pending
- 2016-09-05 US US15/757,816 patent/US20180354962A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2018526405A5 (enExample) | ||
| JP2020505393A5 (enExample) | ||
| JP2018526352A5 (enExample) | ||
| JP2020505400A5 (enExample) | ||
| JP2020505394A5 (enExample) | ||
| JP2020505402A5 (enExample) | ||
| JP2019535792A5 (enExample) | ||
| JP2020514315A5 (enExample) | ||
| JP2020506205A5 (enExample) | ||
| JP2019532110A5 (enExample) | ||
| EP4458348A3 (en) | Pharmaceutical compositions containing substituted polycyclic pyridone derivatives and prodrug thereof | |
| JP2015511613A5 (enExample) | ||
| JP2016531868A5 (enExample) | ||
| JP2013507423A5 (enExample) | ||
| JP2016530259A5 (enExample) | ||
| JP2015500843A5 (enExample) | ||
| JP2015516427A5 (enExample) | ||
| JP2017503760A5 (enExample) | ||
| JP2014510147A5 (enExample) | ||
| JP2016506958A5 (enExample) | ||
| JP2016531858A5 (enExample) | ||
| JP2018504437A5 (enExample) | ||
| JP2015501833A5 (enExample) | ||
| JP2016508506A5 (enExample) | ||
| JP2020500916A5 (enExample) |